XRP Price Prediction for September 26
Most of the coins are not ready yet to keep moving up, according to CoinMarketCap.
XRP/USD
XRP is one of the biggest losers today, falling by 4.41%.
On the hourly chart, the price of XRP is going down after a false breakout of the local resistance of $2.777.
If the situation does not change, one can expect an ongoing drop to the $2.70 zone.
On the longer time frame, the picture is also bearish. If the daily bar closes below the $2.6975 level, the accumulated energy might be enough for a more profound decline to the $2.60-$2.70 range.
From the midterm point of view, bears are more powerful than bulls. If a breakout of the $2.7280 level happens, there is a high chance of seeing a test of the $2.50 mark soon.
XRP is trading at $2.7045 at press time.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BlockDAG's $376M Presale: Leading Blockchain Innovation or Warning Sign?
- BlockDAG's $376M presale achieved 2,660% ROI, selling 25B tokens across 29 batches with $0.0276 per coin pricing. - CEO Antony Turner, ex-SwissOne Capital, leveraged fintech expertise to drive scarcity-based fundraising and community engagement. - Hybrid DAG-PoW architecture and 2.5M X1 Miner users demonstrate technical progress, but $600M target and post-launch stability remain challenges. - Market analysts caution presale success doesn't guarantee long-term utility, emphasizing need for institutional p
U.S. Imposes 100% Tariffs on Pharmaceuticals to Encourage Local Manufacturing, Raising International Trade Worries
- U.S. government imposes 100% tariffs on imported branded/ patented drugs from Oct 1, 2025, unless manufacturers have U.S. production facilities underway. - Policy aims to boost domestic manufacturing via Section 232 national security investigation, as U.S. pharmaceutical imports hit $213B in 2024. - Analysts warn tariffs risk higher drug prices and supply chain disruptions, with Asian markets reacting sharply to potential losses. - Pharma companies show mixed responses: J&J invests $55B in U.S. operation
Institutions Propel RLUSD's Growth as Stablecoin Connects Conventional and Digital Markets
- Ripple's RLUSD stablecoin gains traction as institutional adoption grows via BlackRock/VanEck funds and exchange listings. - Bybit and other exchanges integrate RLUSD for cross-chain settlements, bridging traditional finance and DeFi ecosystems. - Regulatory clarity and $741M market cap position RLUSD as a specialized stablecoin for cross-border payments and tokenized assets. - SEC litigation delays major exchange listings, but proposed GENIUS Act could accelerate institutional-grade stablecoin adoption.
Tether Hits $500B: Stablecoins Laying the Foundation for a Tech Powerhouse
- Tether seeks $20B in funding via 3% equity, targeting a $500B valuation, with SoftBank and Ark Invest in early talks. - The deal would make chairman Giancarlo Devasini the fifth-richest person, with a $224B stake, and elevate Tether to tech giant status. - USDT's $173.5B market cap dwarfs rivals, but regulatory scrutiny over reserves and illicit finance ties persists. - Cantor Fitzgerald's dual role as adviser and custodian raises conflict concerns, while Tether expands U.S. operations with GENIUS Act co
Trending news
MoreCrypto prices
More
